Sep 2026
A Pilot Clinical Trial of Cetuximab Combined With Tislelizumab as Neoadjuvant Therapy for Locally Advanced Oral Squamous Cell Carcinoma.
BACKGROUND Chemotherapy-free neoadjuvant strategies remain undefined for patients with locally advanced oral squamous cell carcinoma (OSCC) who are medically unsuitable for conventional cytotoxic chemotherapy. METHODS In this prospective single-arm pilot trial, 15 patients received two cycles of neoadjuvant tislelizu...
Wen-Jie Wu, Pu-Gen An, Xiao Hu et al.
· Head and Neck · 0 citations